School AbsenteeismNCT05668078
Effectiveness of Rapid Antigen Testing of Students for COVID-19 in Reducing Absences From Schools in Bangladesh
A study testing Rapid Antigen Testing (RAT) for COVID-19 in people with School Absenteeism, run by International Centre for Diarrhoeal Disease Research, Bangladesh at 1 site in Bangladesh.
Trial summary
The goal of this trial is to evaluate the impact of different testing strategies with Rapid Antigen Testing (RAT) on reduction of school absences. RATs are relatively inexpensive, fast, and can be performed at the point of care. Read more about this study
- Who is it for?
- Ages 13 to 19 yearsHealthy volunteers can take part
- Conditions the study is for
- School Absenteeism
- What is being tested?
- Rapid Antigen Testing (RAT) for COVID-19
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 1,141 participants
- Where
- 1 siteBangladesh
- Study dates
- 18 May 2022to 30 Jul 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 13 to 19 years
- All sexes
- Healthy volunteers accepted
- Child, Adult
Who may be able to join
- A day school (not residential), with at least 50 students per classroom that follows the national curriculum in either Bangla or English instruction
- Students of class Nine, Ten and Eight
- Providing written consent for participation (both student and Guardian)
Who cannot join
- Not providing written consent for participation (both student and Guardian)
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Evaluating the Effectiveness of an Intervention Involving Rapid Antigen Testing of Students for COVID-19 in Reducing Absences From Schools in Bangladesh
The goal of this trial is to evaluate the impact of different testing strategies with Rapid Antigen Testing (RAT) on reduction of school absences. RATs are relatively inexpensive, fast, and can be performed at the point of care. Provision of testing in schools will allow rapid identification and isolation of individuals infected with Covid-19. This will likely reduce COVID-19 transmission, as well as allow symptomatic COVID-19 negative students to return to classroom, avoiding the 10-days isolation period. If proven successful, the lessons from this study can be translated to schools in similar settings. While several testing strategies have been proposed and evaluated in developed countries, no studies have evaluated the role of testing for safe operation of schools or reducing absenteeism in developing country contexts.The lessons learned from this study is likely to inform government policy regarding the provision of testing in school.
Study design: Cluster randomized trial
Read more
School types: Three types based on testing:
- Intervention school-1: Test all symptomatic students, teachers, and support staff ; and track symptoms and absenteeism
- Intervention school-2: Test all students, teachers, and support staff every 3 days, irrespective of symptoms (also test whenever develops symptoms) and track symptoms and absenteeism
- Control school: Only track the students for symptom notification and absenteeism
Read the detailed description
Research Design and Methods Study design: Cluster randomized trial School types: Three types based on testing
● School-type 1, intervention school-1: Test all symptomatic participants; and track symptoms and absenteeism
● School-type 2, intervention school-2: Test all participants every three days, irrespective of symptoms (also test whenever develops symptoms), and track symptoms and absenteeism
● In School-type 3, control school: Only track the symptom notification and absenteeism
Trigger testing:
Enrolled students, teachers, and staff will be tested if they are absent from school due COVID-19 like symptoms such as cough, fever, fatigue/ tiredness, headache, loss of taste /loss of smell, sore throat, diarrhoea, shortness of breath/dyspnoea (a person with at least one of the mentioned signs/symptoms at present or within the last five days). These symptoms will be based on the self-report of the individuals. Once a student or staff is absent from school, they will be called to assess their symptoms. If they report COVID-19-like symptoms, they will be asked to come to the testing booth adjacent to their school. If a student arrives at school with any COVID-19-like symptoms or experiences any symptoms during school hours, he/she will be tested immediately.
Study site: Schools in Dhaka, Bangladesh. Selected nine schools
Study Population:
- Students of 9th and 10th grade
- Teachers and support staff Length of data collection: 3 months
Data collection:
Investigator will select three schools meeting the inclusion criteria for the study. Selected schools will be non-residential. The investigator will communicate with the school authorities to confirm their participation prior to the inception of the study. Then invite all the students of classes 9 and 10 and all the teachers and other support staff of the selected school to participate. When the investigator confirms the participant's participation by written consent, collect socio-demographic and health-related information at baseline and begin to follow up with students and teachers.
Sample collection and testing:
Whenever any participant develops any COVID-19-like symptoms, study team will immediately arrange to test their nasal swab samples by Rapid Antigen Test (RAT) on-site and inform them of the result soon after testing. The team will collect two swabs, one for antigen tests and the other for Reverse Transcription Polymerase Chain Reaction (RT-PCR), in case the antigen test is negative. Sample collection to testing completion of RAT may require one hour. Samples that test negative by antigen tests will be tested by RT-PCR, which may take up to 24 hours to get results. Students will stay home until they receive their RT-PCR test results. Swabs will be collected by trained medical technicians of the research team who will be available in school during and after school hours. Sick students will be asked to come to the testing site near the school gate after school hours for testing. The team will collect detailed data on the current signs and symptoms during sample collection. They will also collect information on the current practice of mask use, social distancing, hand washing, travel history, and contact information for the last 14 days from the participants.
Sample testing booth for RAT:
The investigator will select a separate area near the school gate for an on-site sample testing booth. The testing booth area would preferably be inside the school near one side of the school gate, but it can be outside the gate if an arrangement of a booth inside the gate is not suitable. The sample collection booth will remain open after school hours to collect samples who missed school. Two trained medical technologists (MT) of the study team will collect the sample and complete the testing procedure. Both MTs will wear Full PPE during sample collection and ensure standard bio-safety measures while collecting and testing the samples.
If any participants become COVID-19 positive, investigator will recommend ten days of isolation of the positive participant. If the participant is tested negative for RAT and RT-PCR, he/she will continue to attend the school after getting the test result if their health condition permits.
Everyone will be tested routinely in the intervention arm assigned to serial testing, irrespective of their symptoms. In between, if anyone develops symptoms, the team will arrange their sample test immediately.
Communication of test results:
Investigator will send an SMS to the participants immediately with their test results, and positive test results will be communicated via phone and SMS. If anyone needs individual test results, investigator will arrange a hard copy /soft copy of the test report later. Investigator will also send the test results to the school authority by email and or send a hard copy list of test results for their documentation.
RAT testing Kit: "Pnbio COVID-19 AG Papid Tests Device 25T NS".
Outcomes:
- School absence days due to influenza-like symptoms
- Episodes of Influenza-like illness (ILI)/COVID-19-like illness Data Analysis Investigator will compare the socio-demographic characteristics between the control and intervention schools using the chi-square test for binary variables and the student's t-test for continuous variables. Each outcome will be undertaken on an 'intention-to-treat (ITT) basis, i.e., all participants with a recorded outcome will be included in the analyses and will be analyzed according to the intervention arm they were allocated. Investigator will model absenteeism rates (number of ill days per student) as a Poisson variable. Investigator will use generalized estimating equations to compare absenteeism rates and COVID-19 incidence between intervention and control schools while accounting for the clustering in the data from each classroom. This comparison will be made in unadjusted and adjusted analyses using multivariate regression models for potential confounders, including SES, family size, health status, mask use, etc
- Conditions
- School Absenteeism
- Being tested
- Rapid Antigen Testing (RAT) for COVID-19
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Rapid Antigen Testing (RAT) for COVID-19Diagnostic test
COVID-19 RAT intervention done among the school students to see if RAT test can play a role in reducing absenteeism. School type-1-only for symptomatic participants, School type-2-Serial testing at three days interval for all participants and School type-3 got no testing.
| Study group | Role | What they receive |
|---|---|---|
| School-type 1, intervention school-1 | Experimental | We will test all symptomatic students, teachers, and support staff ; and track students symptoms and absenteeism Receives: Diagnostic Test: Rapid Antigen Testing (RAT) for COVID-19 |
| School-type 2, intervention school-2 | Experimental | We will test all students, teachers, and support staff every 3 days, irrespective of symptoms (also test whenever develops symptoms) and track students symptoms and absenteeism Receives: Diagnostic Test: Rapid Antigen Testing (RAT) for COVID-19 |
| In School-type 3, control school | Experimental | We will not do any test, only track the students for symptom notification and absenteeism Receives: Diagnostic Test: Rapid Antigen Testing (RAT) for COVID-19 |
What is being measured
The primary outcome is the main question the study is designed to answer.
The number of days absent
Daily data on school absence was collected prospectively from the school authorities and the cause of absence was collected from the students.
Measured: 10 Weeks
Secondary outcomes (1)
COVID-19 positivity
Measured from total RAT test done and total RAT positive identified in arm -1 and 2
Measured: 10 Weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Dec 2022
- Study start18 May 2022
- Primary completion30 Jul 2022
- Study completion30 Jul 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for School AbsenteeismStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 1,141 participants (actual)
Sponsor and investigators
- Lead sponsor
- International Centre for Diarrhoeal Disease Research, Bangladesh
- Sponsor type
- University, hospital or other
- Collaborators
- Columbia University
- Responsible party
- Sponsor
- Investigators
- Arifa Nazneen, MBBS, MPH, Principal investigator, International Centre for Diarrhoeal Disease Research, Bangladesh
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05668078
- Sponsor's protocol ID
- PR-21078
- Status last verified
- Dec 2022
- First submitted
- 25 Nov 2022
- Last updated
- 29 Dec 2022
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 29 Dec 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluating the Effectiveness of an Intervention Involving Rapid Antigen Testing of Students for COVID-19 in Reducing Absences From Schools in Bangladesh
- ClinicalTrials.gov ID
- NCT05668078
- Acronym / sponsor ID
- PR-21078
- Conditions
- School Absenteeism
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 1,141 participants (actual)
- Lead sponsor
- International Centre for Diarrhoeal Disease Research, BangladeshUniversity, hospital or other
- Collaborators
- Columbia University
- Study start
- 18 May 2022 (actual)
- Primary completion
- 30 Jul 2022 (actual)
- Study completion
- 30 Jul 2022 (actual)
- First posted
- 29 Dec 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this trial is to evaluate the impact of different testing strategies with Rapid Antigen Testing (RAT) on reduction of school absences. RATs are relatively inexpensive, fast, and can be performed at the point of care. Provision of testing in schools will allow rapid identification and isolation of individuals infected with Covid-19. This will likely reduce COVID-19 transmission, as well as allow symptomatic COVID-19 negative students to return to classroom, avoiding the 10-days isolation period. If proven successful, the lessons from this study can be translated to schools in similar settings. While several testing strategies have been proposed and evaluated in developed countries, no studies have evaluated the role of testing for safe operation of schools or reducing absenteeism in developing country contexts.The lessons learned from this study is likely to inform government policy regarding the provision of testing in school.
Study design: Cluster randomized trial
School types: Three types based on testing:
- Intervention school-1: Test all symptomatic students, teachers, and support staff ; and track symptoms and absenteeism
- Intervention school-2: Test all students, teachers, and support staff every 3 days, irrespective of symptoms (also test whenever develops symptoms) and track symptoms and absenteeism
- Control school: Only track the students for symptom notification and absenteeism
Detailed description
Research Design and Methods Study design: Cluster randomized trial School types: Three types based on testing
● School-type 1, intervention school-1: Test all symptomatic participants; and track symptoms and absenteeism
● School-type 2, intervention school-2: Test all participants every three days, irrespective of symptoms (also test whenever develops symptoms), and track symptoms and absenteeism
● In School-type 3, control school: Only track the symptom notification and absenteeism
Trigger testing:
Enrolled students, teachers, and staff will be tested if they are absent from school due COVID-19 like symptoms such as cough, fever, fatigue/ tiredness, headache, loss of taste /loss of smell, sore throat, diarrhoea, shortness of breath/dyspnoea (a person with at least one of the mentioned signs/symptoms at present or within the last five days). These symptoms will be based on the self-report of the individuals. Once a student or staff is absent from school, they will be called to assess their symptoms. If they report COVID-19-like symptoms, they will be asked to come to the testing booth adjacent to their school. If a student arrives at school with any COVID-19-like symptoms or experiences any symptoms during school hours, he/she will be tested immediately.
Study site: Schools in Dhaka, Bangladesh. Selected nine schools
Study Population:
- Students of 9th and 10th grade
- Teachers and support staff Length of data collection: 3 months
Data collection:
Investigator will select three schools meeting the inclusion criteria for the study. Selected schools will be non-residential. The investigator will communicate with the school authorities to confirm their participation prior to the inception of the study. Then invite all the students of classes 9 and 10 and all the teachers and other support staff of the selected school to participate. When the investigator confirms the participant's participation by written consent, collect socio-demographic and health-related information at baseline and begin to follow up with students and teachers.
Sample collection and testing:
Whenever any participant develops any COVID-19-like symptoms, study team will immediately arrange to test their nasal swab samples by Rapid Antigen Test (RAT) on-site and inform them of the result soon after testing. The team will collect two swabs, one for antigen tests and the other for Reverse Transcription Polymerase Chain Reaction (RT-PCR), in case the antigen test is negative. Sample collection to testing completion of RAT may require one hour. Samples that test negative by antigen tests will be tested by RT-PCR, which may take up to 24 hours to get results. Students will stay home until they receive their RT-PCR test results. Swabs will be collected by trained medical technicians of the research team who will be available in school during and after school hours. Sick students will be asked to come to the testing site near the school gate after school hours for testing. The team will collect detailed data on the current signs and symptoms during sample collection. They will also collect information on the current practice of mask use, social distancing, hand washing, travel history, and contact information for the last 14 days from the participants.
Sample testing booth for RAT:
The investigator will select a separate area near the school gate for an on-site sample testing booth. The testing booth area would preferably be inside the school near one side of the school gate, but it can be outside the gate if an arrangement of a booth inside the gate is not suitable. The sample collection booth will remain open after school hours to collect samples who missed school. Two trained medical technologists (MT) of the study team will collect the sample and complete the testing procedure. Both MTs will wear Full PPE during sample collection and ensure standard bio-safety measures while collecting and testing the samples.
If any participants become COVID-19 positive, investigator will recommend ten days of isolation of the positive participant. If the participant is tested negative for RAT and RT-PCR, he/she will continue to attend the school after getting the test result if their health condition permits.
Everyone will be tested routinely in the intervention arm assigned to serial testing, irrespective of their symptoms. In between, if anyone develops symptoms, the team will arrange their sample test immediately.
Communication of test results:
Investigator will send an SMS to the participants immediately with their test results, and positive test results will be communicated via phone and SMS. If anyone needs individual test results, investigator will arrange a hard copy /soft copy of the test report later. Investigator will also send the test results to the school authority by email and or send a hard copy list of test results for their documentation.
RAT testing Kit: "Pnbio COVID-19 AG Papid Tests Device 25T NS".
Outcomes:
- School absence days due to influenza-like symptoms
- Episodes of Influenza-like illness (ILI)/COVID-19-like illness Data Analysis Investigator will compare the socio-demographic characteristics between the control and intervention schools using the chi-square test for binary variables and the student's t-test for continuous variables. Each outcome will be undertaken on an 'intention-to-treat (ITT) basis, i.e., all participants with a recorded outcome will be included in the analyses and will be analyzed according to the intervention arm they were allocated. Investigator will model absenteeism rates (number of ill days per student) as a Poisson variable. Investigator will use generalized estimating equations to compare absenteeism rates and COVID-19 incidence between intervention and control schools while accounting for the clustering in the data from each classroom. This comparison will be made in unadjusted and adjusted analyses using multivariate regression models for potential confounders, including SES, family size, health status, mask use, etc
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| School-type 1, intervention school-1 | Experimental | Diagnostic Test: Rapid Antigen Testing (RAT) for COVID-19We will test all symptomatic students, teachers, and support staff ; and track students symptoms and absenteeism |
| School-type 2, intervention school-2 | Experimental | Diagnostic Test: Rapid Antigen Testing (RAT) for COVID-19We will test all students, teachers, and support staff every 3 days, irrespective of symptoms (also test whenever develops symptoms) and track students symptoms and absenteeism |
| In School-type 3, control school | Experimental | Diagnostic Test: Rapid Antigen Testing (RAT) for COVID-19We will not do any test, only track the students for symptom notification and absenteeism |
Who may qualify
- Ages
- 13 to 19 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult
Key inclusion criteria (3 listed)
- A day school (not residential), with at least 50 students per classroom that follows the national curriculum in either Bangla or English instruction
- Students of class Nine, Ten and Eight
- Providing written consent for participation (both student and Guardian)
Key exclusion criteria (1 listed)
- Not providing written consent for participation (both student and Guardian)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Rapid Antigen Testing (RAT) for COVID-19COVID-19 RAT intervention done among the school students to see if RAT test can play a role in reducing absenteeism. School type-1-only for symptomatic participants, School type-2-Serial testing at three days interval for all participants and School type-3 got no testing. | Diagnostic test | In School-type 3, control school, School-type 1, intervention school-1, School-type 2, intervention school-2 |
Primary outcome
The number of days absent
Time frame: 10 Weeks
Daily data on school absence was collected prospectively from the school authorities and the cause of absence was collected from the students.
1 secondary outcome
COVID-19 positivity
Time frame: 10 Weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 29 Dec 2022.
- Individual participant dataSharing planned: No
Related trials for School Absenteeism
Not yet recruiting
Early Absenteeism Guide for Lifelong Education
Absenteeism, School Absenteeism
Recruiting
Impact Evaluation of Accelerating Climate-Resilient Water, Sanitation and Hygiene Services for Schools and Healthcare Facilities in Karamoja
Diarrhea, Respiratory Tract Infections (RTI)
Recruiting
Grow With Grit: A School Nurse-Led SBIRT Pilot for Early Anxiety Detection
Anxiety
Enrolling by invitation
Classroom Air Purifiers for Reducing School Absence
Asenteeism
Enrolling by invitation
A Study of School Absenteeism and Student Well-being in Elementary Schools
School Absenteeism, Anxiety and Depression
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Arifa Nazneen, MBBS, MPH principal investigator
International Centre for Diarrhoeal Disease Research, Bangladesh
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Rapid Antigen Testing (RAT) for COVID-19 in people with School Absenteeism, run by International Centre for Diarrhoeal Disease Research, Bangladesh at 1 site in Bangladesh.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 29 Dec 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Bangladesh. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
The number of days absent (time frame: 10 Weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Dec 2022.